pfizer glp 1 drug Pfizer's Push into GLP‑1 Drugs Signals a New Era in Obesity Treatment — and a Danuglipron: Pfizer's GLP-1 receptor agonist
Description
Whats the difference between GLP-1 and dual agonists

Pancreatitis: Case studies and a few of the clinical trials on GLP-1 RAs for diabetes have raised the possibility of pancreatitis being triggered by these drugs due to the potential growth in cells in the pancreas
Fruhbeck G, Kiortsis DN, Catalan V

E., Bittencourt, P

GLP-1 medications are currently considered long-term treatments

Semaglutide, among other antidiabetic drugs, has shown an association with cancer as it alters the rates of tumorigenesis and proliferation